Voices from the Doximity Network
Julie R Gralow, MD
Jan 30, 2023
James Friebe
Jan 9, 2023 Link to Chatting with the Crohn's & Colitis Foundation's CEO Before the 2023 Crohn's & Colitis Congress
Lynne Lederman, PhD
Dec 19, 2022 Link to First-in-Class Agent Addresses Unmet Need in Myeloma
Dec 19, 2022 Link to Questioning the Status Quo for Children with ALL at ASH
Dec 19, 2022 Link to Pausing Endocrine Therapy to Attempt Pregnancy Does Not Increase Short-Term Breast Cancer Recurrence
Dec 19, 2022 Link to Screening for Breast Cancer by Genetics or Imaging in Community Settings
Hardeep Singh Phull, MD
Dec 19, 2022 Link to How the Post-COVID ASH Conference 2022 Provided a Platform to Nourish the Human Spirit with Work, Play, and Friendship
Stephen Douglas Smith, MD
Dec 19, 2022 Link to Mantle Cell Lymphoma at ASH 2022 – More Answers, and More Questions
Samuel Kareff, MD MPH
Dec 19, 2022 Link to Benefits of Virtual Conference Attendance: ASH 2022 Edition
Hayder Saeed, MD
Dec 19, 2022 Link to Are We Ready for a Newer Cellular Therapy Approach in Mature T Cell Lymphoma?
Heather Moore, CPP, PharmD and 1 other
Dec 19, 2022 Link to Advances in the Treatment of Hormone Receptor Positive and HER-2 Positive Breast Cancer
Suzanne Baga, MA, RRT
Dec 19, 2022 Link to Interview with SABCS 2022 Co-Director Dr. Virginia Kaklamani
David Rimm MD-PhD
Dec 18, 2022 Link to HER2-Low, A Separate Entity?
Katharine Yao, MD
Dec 18, 2022 Link to Contralateral Breast Cancer in Breast Cancer Patients with Germline Mutations
Kalliopi Siziopikou, MD PhD
Dec 18, 2022 Link to HER2 Low Breast Cancer: Pathology Issues for Accurate HER2 testing
Kimberly J. Van Zee, MS, MD, FACS
Dec 18, 2022 Link to Predicting Risk of Recurrence for DCIS: Do Commercially Available Genomic Assays Have Proven Added Value Over and Above the MSKCC DCIS Nomogram? And if Not, Why Should We Pay For Them?
Jordan Axelrad, MD, MPH
Dec 11, 2022 Link to AIBD 2022: Cancer in Patients With Inflammatory Bowel Disease
Alan Colm Moss, MD FACG, AGAF, FEBG, FRCPI
Dec 11, 2022 Link to A Holistic View of Assessing Disease Severity in Inflammatory Bowel Disease (IBD)
Raymond Keith Cross Jr., MD MS, AGAF, FACG
Dec 11, 2022 Link to Steroids: Never or Forever
Seethal A. Jacob, MD MS and 1 other
Dec 5, 2022 Link to ASH 2022: Sickle Cell Disease in the Big Easy
Douglas Katz, MD
Dec 5, 2022 Link to RSNA 2022 Annual Meeting: Three Years Later To Live in the Flesh in Chicago, or Teleportation via a Time Warp?
Burton Eliot Appel, MD ,MBA
Dec 5, 2022 Link to ASH 2022 Preview of an Education Session: Reproductive and Sexual Health in Sickle Cell Disease
